The company's lack of profitability and decreasing revenue justify the share price decline. The stock could be worth watching if revenue improves. However, long-term share price weakness and 2 warning signs with Orient Group Incorporation could be concerning for investors.

Investors may be skeptical about the company's ability to maintain strong revenue performance, despite its forecasted growth being higher than its industry. This could explain the significantly depressed P/S ratio.

The company's long-term performance has been poor, making it a risky investment. The recent rise in share price should be approached with caution given the company's long-term underperformance.

Despite a rise in share price, Shaanxi Kanghui Pharmaceutical's P/S ratio lags behind others, possibly due to expectations of continued limited growth. A reversal in share price fortunes seems unlikely if trends persist.

Despite solid earnings growth, the company's high P/E ratio compared to recent growth rates may be worrisome. Investors hoping for a business turnaround may face disappointment if the P/E falls in line with recent growth rates. Continuation of medium-term earnings trends could pose a significant risk to shareholders' investments, with potential investors possibly paying an excessive premium.

Investors believe the company may underperform the industry, causing a low P/S ratio. The company's shrinking revenue and lack of potential for improvement could lead to an even lower P/S ratio.